Virbac Provides Vets With Reproductive Educational Resource Following WSAVA Guidelines Publication
3 months ago 
501 views
The recently published WSAVA global guidelines in reproduction control have highlighted the latest science based information on neutering and detail the potential benefits of non-surgical castration.
In response to the new scientific evidence and seismic shift in thinking on the current practices of neutering, Virbac is pleased to offer veterinary surgeons & veterinary nurses the opportunity to access a range of reproductive learning content, covering key points of the WSAVA’s report and up-to-date information and advice. The summary of the report can be found here: https://bit.ly/WSAVAneutering
‘There is so much new information coming through that vets need to assimilate’ said Dr Neil Mottram, Technical Manager at Virbac. ‘So the educational reproductive resource is designed to make that journey easier to navigate and provide vets with easy access to up to the minute information on key issues in the report’.
The report highlights concerns about increasing moves to early neutering, or for neutering to be used as a method of behavioural control, as not all aggressive behaviours are testosterone related, so, using a “castration trial’ with long-acting GnRH agonist is recommended by the report before irreversible orchiectomy is performed. In addition, there is also evidence that gonadectomy may contribute to the development of some tumours, which is currently under intense investigation, as is the effect of age at castration
SUPRELORIN® is a sustained release implant containing deslorelin (a GnRH super agonist) and is licensed for use in sexually mature male dogs and cats from 3months of age that have not been neutered to make them temporarily infertile. The implant is inserted subcutaneously, under the loose skin on the back between the lower neck and the lumbar area. Conveniently, implantation is a quick procedure and does not require anaesthesia or hospitalisation.
SUPRELORIN® is available in two presentations, a 4.7mg implant which lasts for at least 6 months and a 9.4mg implant which lasts for at least 12 months in dogs.
For more information on the new guidelines, the Virbac reproductive learning content and SUPRELORIN®, or any of the other products in the Virbac reproduction portfolio, please speak to your Virbac Territory Manager.
More from Virbac Animal Health
- Virbac Announce the Arrival of Syvazul BTV3, a Bluetongue Vaccine for Sheep & Cattle, Into the UK
- Will Balhatchet crowned Young Dairy Vet of the Year 2024
- ‘Twist Your View on Otitis Treatment’: Virbac Invites Delegates to Complimentary CPD Webinar
- Virbac Announces the Arrival of Canigen® Bb, A New Injectable Bordetella Bronchiseptica Vaccine for Dogs
- New Advanced Oral Care Now Available in the Virbac VETERINARY HPM® Small & Toy Range
3 days ago